Rangappa S - Search Results

1

Topical Pilocarpine Formulation for Diagnosis of Cystic Fibrosis.

Fatima T, Ajjarapu S, Shankar VK, Rangappa S, Shivakumar HN, Biswas SK, Hoque M, Murthy SN. Fatima T, et al. Among authors: rangappa s. J Pharm Sci. 2020 May;109(5):1747-1751. doi: 10.1016/j.xphs.2020.01.030. Epub 2020 Feb 6. J Pharm Sci. 2020. PMID: 32035925

2

Antiallodynic and Antihyperalgesic Activities of Fentanyl-Loaded Dermal Clay Dressings in Rat Model of Second-Degree Burn Injury.

Rangappa S, Rangan KK, Sudarshan TS, Murthy SN. Rangappa S, et al. J Pharm Sci. 2018 Oct;107(10):2628-2634. doi: 10.1016/j.xphs.2018.06.005. Epub 2018 Jun 18. J Pharm Sci. 2018. PMID: 29920252

3

Evaluation of soluble fentanyl microneedles for loco-regional anti-nociceptive activity.

Maurya A, Rangappa S, Bae J, Dhawan T, Ajjarapu SS, Murthy SN. Maurya A, et al. Among authors: rangappa s. Int J Pharm. 2019 Jun 10;564:485-491. doi: 10.1016/j.ijpharm.2019.04.066. Epub 2019 Apr 23. Int J Pharm. 2019. PMID: 31026490

4

A Rapid Tool to Optimize Process Variables for Continuous Manufacturing of Metronidazole Ointment Using Melt Extrusion Technique.

Ajjarapu S, Rangappa S, Shankar VK, Shettar A, Kumar HNS, Kulkarni VI, Repka MA, Murthy SN. Ajjarapu S, et al. Among authors: rangappa s. AAPS PharmSciTech. 2020 Oct 6;21(7):273. doi: 10.1208/s12249-020-01808-8. AAPS PharmSciTech. 2020. PMID: 33030634

5

Chemotherapeutic Agent-Induced Vulvodynia, an Experimental Model.

Rangappa S, Shankar VK, Jo S, Repka MA, Murthy SN. Rangappa S, et al. AAPS PharmSciTech. 2021 Mar 8;22(3):95. doi: 10.1208/s12249-021-01969-0. AAPS PharmSciTech. 2021. PMID: 33686480

6

Development and Validation of HPLC Method for Efinaconazole: Application to Human Nail Permeation Studies.

Kolimi P, Shankar VK, Shettar A, Rangappa S, Repka MA, Murthy SN. Kolimi P, et al. Among authors: rangappa s. AAPS PharmSciTech. 2022 Jan 28;23(1):63. doi: 10.1208/s12249-021-02196-3. AAPS PharmSciTech. 2022. PMID: 35091878

7

Effect of Lipid Vehicles on Solubility, Stability, and Topical Permeation of Delta-9-Tetrahydrocannabinol.

Shankar VK, Shettar A, Rangappa S, Ellis I, Dave M, Murthy R, Murthy SN. Shankar VK, et al. Among authors: rangappa s. AAPS PharmSciTech. 2022 Aug 12;23(6):223. doi: 10.1208/s12249-022-02385-8. AAPS PharmSciTech. 2022. PMID: 35962264

8

Correction to: Effect of Lipid Vehicles on Solubility, Stability, and Topical Permeation of Delta-9-Tetrahydrocannabinol.

Shankar VK, Shettar A, Rangappa S, Ellis I, Dave M, Murthy R, Murthy SN. Shankar VK, et al. Among authors: rangappa s. AAPS PharmSciTech. 2022 Aug 25;23(7):240. doi: 10.1208/s12249-022-02399-2. AAPS PharmSciTech. 2022. PMID: 36002709 No abstract available.

9

Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.

Matadh AV, Jakka D, Pragathi SG, Rangappa S, Shivakumar HN, Maibach H, Reena NM, Murthy SN. Matadh AV, et al. Among authors: rangappa s. AAPS PharmSciTech. 2022 Nov 30;24(1):9. doi: 10.1208/s12249-022-02471-x. AAPS PharmSciTech. 2022. PMID: 36450897

10

Sublimation of Drugs from the Site of Application of Topical Products.

S G P, Echanur AV, Matadh AV, Rangappa S, H N S, Murthy RN, V S R, Ureña-Benavides EE, Maibach H, Murthy SN. S G P, et al. Among authors: rangappa s. Mol Pharm. 2023 Jun 5;20(6):2814-2821. doi: 10.1021/acs.molpharmaceut.2c00816. Epub 2023 Jan 10. Mol Pharm. 2023. PMID: 36625731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page